Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.

PloS one - 1 Jan 2012

Huang Shu-Pin, Bao Bo-Ying, Hour Tzyh-Chyuan, Huang Chao-Yuan, Yu Chia-Cheng, Liu Chia-Chu, Lee Yung-Chin, Huang Chun-Nung, Pao Jiunn-Bey, Huang Chun-Hsiung

Abstract excerpt

Several genome-wide association studies (GWAS) have been conducted to identify the common single nucleotide polymorphisms (SNPs) that influence the risk of prostate cancer. It was hypothesized that some prostate cancer-associated SNPs might relate to the clinical outcomes in patients treated for prostate cancer using androgen-deprivation therapy (ADT). A cohort of 601 patients who have received ADT for prostate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Androgens
Share to Caspase 3

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Disease Progression

Share to Genetic Loci

Share to Insulin Receptor Substrate Proteins

Share to Prostatic Neoplasms

Share to Survival Analysis

Source

Open in PubMed Open full text

Identifiers

PMID: 22844442
DOI: 10.1371/journal.pone.0041219
PMCID: PMC3402522

Genes

BMP5
IRS2
CASP3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy.PMID 22844442Read ↗

Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy.Semantic proximity Read ↗

Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Molecular markers in sex hormone pathway genes associated with the efficacy of androgen-deprivation therapy for prostate cancer.Semantic proximity Read ↗

Polymorphisms inside microRNAs and microRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy.Semantic proximity Read ↗

Association of Missense Polymorphism inHSD3B1With Outcomes Among Men With Prostate Cancer Treated With Androgen-Deprivation Therapy or AbirateroneSemantic proximity Read ↗

PTBP1 Genetic Variants Affect the Clinical Response to Androgen-deprivation Therapy in Patients With Prostate Cancer.Semantic proximity Read ↗

Insulin-like Growth Factor Pathway Genetic Polymorphisms, Circulating IGF1 and IGFBP3, and Prostate Cancer SurvivalSemantic proximity Read ↗

Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer.Semantic proximity Read ↗

Insulin-like growth factor pathway genetic polymorphisms, circulating IGF1 and IGFBP3, and prostate cancer survival.Semantic proximity Read ↗

Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients.Semantic proximity Read ↗

Association of prostate cancer risk Loci with disease aggressiveness and prostate cancer-specific mortality.Semantic proximity Read ↗

Genome-wide association study of prostate cancer-specific survival.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.